These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11232015)

  • 1. Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy.
    Bonnet E; Ruidavets JB; Tuech J; Ferrières J; Collet X; Fauvel J; Massip P; Perret B
    J Clin Endocrinol Metab; 2001 Jan; 86(1):296-302. PubMed ID: 11232015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
    Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F;
    Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients.
    Fauvel J; Bonnet E; Ruidavets JB; Ferrières J; Toffoletti A; Massip P; Chap H; Perret B
    AIDS; 2001 Dec; 15(18):2397-406. PubMed ID: 11740190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
    Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
    Atherosclerosis; 2004 Feb; 172(2):273-9. PubMed ID: 15019537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
    Martínez E; García-Viejo MA; Blanco JL; Bianchi L; Buira E; Conget I; Casamitjana R; Mallolas J; Gatell JM
    Clin Infect Dis; 2000 Nov; 31(5):1266-73. PubMed ID: 11073762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters.
    Maher B; Lloyd J; Wilkins EG; Fraser WD; Back D; Park BK; Pirmohamed M
    Antivir Ther; 2004 Dec; 9(6):879-87. PubMed ID: 15651746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
    Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
    HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
    Yanovski JA; Miller KD; Kino T; Friedman TC; Chrousos GP; Tsigos C; Falloon J
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1925-31. PubMed ID: 10372688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of protease inhibitors on glucose tolerance, lipid metabolism, and body composition in children and adolescents infected with human immunodeficiency virus.
    Ergun-Longmire B; Lin-Su K; Dunn AM; Chan L; Ham K; Sison C; Stavola J; Vogiatzi MG
    Endocr Pract; 2006; 12(5):514-21. PubMed ID: 17014060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
    Negredo E; Ribalta J; Paredes R; Ferré R; Sirera G; Ruiz L; Salazar J; Reiss P; Masana L; Clotet B
    AIDS; 2002 Jul; 16(10):1383-9. PubMed ID: 12131215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.
    Petit JM; Duong M; Duvillard L; Piroth L; Grappin M; Verges B; Chavanet P; Brun JM; Portier H
    Horm Metab Res; 2000 Sep; 32(9):367-72. PubMed ID: 11014386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
    Viganò A; Aldrovandi GM; Giacomet V; Merlo M; Martelli L; Beretta S; Luraschi P; Rombolà G; Mora S
    Antivir Ther; 2005; 10(8):917-24. PubMed ID: 16430197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.
    Chen D; Misra A; Garg A
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4845-56. PubMed ID: 12414837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.
    Temple ME; Koranyi KI; Nahata MC
    Ann Pharmacother; 2003 Sep; 37(9):1214-8. PubMed ID: 12921501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
    Hadigan C; Meigs JB; Corcoran C; Rietschel P; Piecuch S; Basgoz N; Davis B; Sax P; Stanley T; Wilson PW; D'Agostino RB; Grinspoon S
    Clin Infect Dis; 2001 Jan; 32(1):130-9. PubMed ID: 11118392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
    Hadigan C; Rabe J; Meininger G; Aliabadi N; Breu J; Grinspoon S
    Am J Clin Nutr; 2003 Feb; 77(2):490-4. PubMed ID: 12540412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women.
    Fernandez ML; Metghalchi S; Vega-López S; Conde-Knape K; Lohman TG; Cordero-Macintyre ZR
    J Nutr Biochem; 2004 Dec; 15(12):717-21. PubMed ID: 15607644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.